From: Fibroblast growth factor-23 rs7955866 polymorphism and risk of chronic kidney disease
Parameter | GG (N = 34) | GA (N = 28) | AA (N = 10) | Statistical test | P |
---|---|---|---|---|---|
Hypertension Grade | 2 (0.75–3) | 2.5 (1–3) | 4 (2.75–4.25) | KWH | 0.003** |
S. Creatinine (mg/dL) | 1.45 (1.2–1.7) | 1.65 (1.1–2) | 1.50 (1.1–1.83) | KWH | 0.619 |
GFR-EPI (mL/min/1.73) | 45.68 (36.75–60.52) | 42.53 (34.01–64.44) | 41.84 (37.55–64.76) | KWH | 0.913 |
Proteinuria (gm/day) | 2.16 (1.17–3.96) | 2.18 (1.09–4.14) | 1.83 (1.19–3.96) | KWH | 0.988 |
S. Urea (mg/dL) | 79.91 ± 20.56 | 84.07 ± 21.83 | 79.30 ± 18.34 | ANOVA | 0.693 |
S. Uric Acid (mg/dL) | 7.74 ± 2.43 | 7.33 ± 2.33 | 6.35 ± 2.61 | ANOVA | 0.278 |
S. Proteins (gm/dL) | 6.41 ± 0.78 | 6.39 ± 0.79 | 5.95 ± 0.77 | ANOVA | 0.242 |
S. Albumin (gm/dL) | 3.35 (2.58–3.73) | 3.15 (2.9–3.4) | 2.5 (2.45–3.05) | KWH | 0.007** |
S. Calcium (mg/dL) | 9.04 ± 0.86 | 9.24 ± 0.86 | 8.81 ± 0.95 | ANOVA | 0.37 |
S. Phosphorus (mg/dL) | 4.75 (4.10–5.93) | 4.55 (3.95–5.1) | 5.3 (4.13–5.78) | KWH | 0.368 |
S. iPTH (pg/mL) | 127.5 (101.3–192.3) | 178 (111–221) | 133.5 (74.5–237) | KWH | 0.387 |
S. Vitamin D3 (ng/mL) | 14.75 (12–19.75) | 13.25 (11.13–22) | 17 (14.25–26.1) | KWH | 0.268 |
S. iFGF23 (pg/mL) | 676.71 (409.49–916.85) | 729.19 (544.03–970.98) | 879.53 (791.83–1486.7) | KWH | 0.038* |
Hemoglobin (gm/dL) | 10.49 ± 1.28 | 10.22 ± 1.20 | 10.42 ± 1.33 | ANOVA | 0.708 |
WBCs (k/uL) | 7.75 (5.78–9.85) | 7.65 (6.75–9.45) | 5.78 (5.13–7.33) | KWH | 0.09 |
Platelets (k/uL) | 304.24 ± 77.12 | 282.18 ± 68.27 | 311.20 ± 84.47 | ANOVA | 0.416 |